CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Vous n'êtes pas connecté
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
VIRC's fiscal second-quarter results are likely to reflect a solid vertically integrated model and operating capabilities.
Adobe's fiscal third-quarter results are likely to reflect solid momentum across Creative Cloud and Document Cloud.
ORCL's fiscal first-quarter results are likely to reflect rapid adoption and progress in AI-based cloud services offering potential for future...
LTRX Q4 fiscal 2024 performance is likely to have gained from the uptake of its solutions across its Smart Cities, Automotive and Enterprise business...
LTRX Q4 fiscal 2024 performance is likely to have gained from the uptake of its solutions across its Smart Cities, Automotive and Enterprise business...
RBRK's fiscal second-quarter performance is likely to reflect benefits from its expanding clientele and increased demand for its data security...
Zscaler's fiscal fourth-quarter performance reflects increased success in selling bigger bundles and strong customer traction for the Zero Trust...
Zscaler's fiscal fourth-quarter performance reflects increased success in selling bigger bundles and strong customer traction for the Zero Trust...
ADBE's fiscal third-quarter results are likely to reflect the impacts of its strength in generative AI and positive contributions from partnerships.